 |

Antibiotic
Susceptibility: Endophthalmitis
Susceptibility
of Bacterial Isolates from Endophthalmitis to Common Antibiotics
(Percent Susceptible) (1993- January 1, 2009) |
| Bacteria |
# |
VAN |
GEN |
CIP |
OFX |
CEF |
AMK |
CAZ |
OXA |
AMP |
CLIN |
GAT |
MOX |
| Coag-Neg
Staphylococcus |
286 |
100 |
84 |
51 |
47 |
98 |
96 |
69 |
48 |
17 |
80 |
67
(108) |
62
(108) |
| Staphylococcus
aureus |
54 |
100 |
91 |
48 |
43 |
85 |
78 |
70 |
67 |
9 |
56 |
31
(16) |
38
(16) |
| Streptococcus
species |
94 |
100 |
48 |
81 |
92 |
94 |
10 |
87 |
-- |
96 |
81 |
97
(32) |
97
(32) |
| Gram-Negative
Bacteria |
35 |
12 |
91 |
89 |
89 |
32 |
94 |
91 |
-- |
37 |
10 |
86
(14) |
86
(14) |
| Other
Gram-Positive Bacteria |
23 |
96 |
83 |
82 |
79 |
61 |
83 |
45 |
-- |
65 |
82 |
75
(4) |
75
(4) |
| |
| * Disk diffusion susceptibilities based on NCCLS serum standards. |
| VAN=Vancomycin;
GEN=Gentamicin; CIP=Ciprofloxacin; OFX=Ofloxacin; CEF=Cefazolin;
AMK=Amikacin; CAZ=Ceftazidime; OXA=Oxacillin; AMP=Ampicillin;
CLIN=Clindamicin; (--)=not done |
Susceptibility*
of Gram Negative Isolates from Endophthalmitis to Common Antibiotics
(Percent Susceptible)(1993 to January 1, 2008) |
| Bacteria |
# |
GEN |
CIP |
OFX |
Amikacin |
Ceflaz |
GAT |
MOX |
| Acinetobacter
lwoffii |
1 |
100 |
100 |
- |
100 |
100 |
- |
- |
|
| Alcaligenes
xylosoxidans |
1 |
0 |
100 |
100 |
0 |
100 |
100 |
- |
| Enterobacter
agglomerans |
2 |
100 |
100 |
100 |
100 |
100 |
100(1) |
100(1) |
| Escherichia
coli |
1 |
100 |
100 |
100 |
100 |
100 |
- |
- |
| Flavimones oryzihabitans |
1 |
100 |
100 |
- |
100 |
100 |
- |
- |
| Hafnia alvei |
1 |
100 |
100 |
100 |
100 |
100 |
100 |
100 |
| Haemophilus spp |
6 |
83 |
100 |
100(5) |
67 |
83 |
100(2) |
100(2) |
| Morganella
morgannii |
3 |
67 |
67 |
50(2) |
100 |
33 |
50(2) |
50(2) |
| Moraxella spp |
2 |
100 |
100 |
100 |
100(1) |
100 |
100(1) |
100(1) |
| Pseudomonas aeruginosa |
6 |
83 |
83 |
67(3) |
83 |
83 |
50(2) |
50(2) |
| Burkholderia cepacia |
1 |
100 |
100 |
100 |
100 |
0 |
- |
- |
| Pseudomonas
testeroni |
1 |
100 |
100 |
100 |
100 |
100 |
- |
- |
| Pseudomonas vesicularis |
1 |
100 |
0 |
0 |
100 |
100 |
100 |
100 |
| Proteus
mirabilis |
1 |
100 |
100 |
100 |
100 |
100 |
- |
- |
| Proteus
vulgaris |
1 |
100 |
100 |
100 |
100 |
100 |
100 |
100 |
| Stenotrophomonas
maltophilia |
1 |
100 |
0 |
0 |
100 |
100 |
- |
- |
| Serratia marcescens |
4 |
100 |
75 |
100 |
100 |
100 |
100(1) |
100(1) |
| All |
34 |
88 |
85 |
85 |
88 |
85 |
85(13) |
85(13) |
| |
| * Disk diffusion susceptibilities based on NCCLS serum standards. |
| BAC=Bacitracin;
VAN=Vancomycin; GEN=Gentamicin; CIP=Ciprofloxacin;
OFX=Ofloxacin; PB=Polymyxin B; CEF=Cefazolin;
TOB=Tobramycin; SULF=Sulfasoxazole; OXA=Oxacillin; (--)=not
done. |

|
 |
|